Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
08/12/2021 -- Results Q2 2021 -1.40 -1.40 0.00%
08/12/2021 16:30 EST Earnings Call Q2 2021 -- -- --
05/06/2021 16:30 EST Earnings Call Q1 2021 -- -- --
05/06/2021 -- Results Q1 2021 -1.40 -1.40 0.00%
03/25/2021 16:30 EST Earnings Call Q4 2020 -- -- --
03/25/2021 -- Results Q4 2020 -1.40 -1.58 11.11%
11/12/2020 16:30 EST Earnings Call Q3 2020 -- -- --
11/12/2020 -- Results Q3 2020 -- -- --
*Estimated Date/Time

Earnings

Next Report Date --
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 08/12/2021
Beat/Miss Upgrade
Return Since -89.99%
Last FQE 09/30/2022
Next FQE 12/30/2022

Profile

Edit
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available direct to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
URL https://www.novabay.com
Investor Relations URL http://novabay.com/investors/
HQ State/Province California
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Value
Next Earnings Release N/A
Last Earnings Release Aug. 12, 2021
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
-87.17%
63.37%
16.67%
-79.93%
-17.17%
8.91%
-45.97%
-82.70%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-14.29%
-9.04%
-23.93%
70.05%
-17.52%
10.42%
-13.60%
-24.30%
-67.01%
-18.25%
-29.46%
-55.16%
-57.46%
-66.95%
321.7%
-47.71%
-88.12%
56.85%
-66.70%
-33.39%
-96.85%
-9.48%
-24.44%
-28.93%
-74.38%
2.04%
-67.38%
352.1%
-90.30%
47.67%
172.7%
-64.15%
-94.95%
As of November 25, 2022.

Profile

Edit
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available direct to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
URL https://www.novabay.com
Investor Relations URL http://novabay.com/investors/
HQ State/Province California
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Value
Next Earnings Release N/A
Last Earnings Release Aug. 12, 2021
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

No data available
Symbol Dollars Invested % Weight
     
     
     
     
     
     
     
     
     
     

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter NBY Tweets